Helmut Jeggle is a businessperson who has been at the helm of 23 different companies. Currently, he occupies the position of Chairman-Supervisory Board of BioNTech SE, Managing Director at AT Newtec GmbH, Co-Managing Director at Jossa Arznei GmbH, Co-Managing Director at Santo Service GmbH, Managing Director at Avitop GmbH, Co-Chief Executive Officer for Neuraxpharm Holding GmbH, Managing Director & Chief Financial Officer at Nx Biotech GmbH, Managing Director at Horus Sentilo Projektentwicklungsgesellschaft mbH, Chief Executive Officer for Salvia GmbH, Co-Managing Director at SWB Holding GmbH (Bayern), Co-Managing Director at A&T Grundstück 1 GmbH, Co-Managing Director at A&T Grundstück 2 GmbH, Co-Managing Director at Palais Berlin 1 GmbH, Chairman-Supervisory Board at AiCuris Anti-infective Cures GmbH, Co-Managing Director at Santo Holding (Deutschland) GmbH, Chief Operating Officer & Co-Managing Director at Athos Service GmbH, Co-Managing Director at Objektgesellschaft Berlin Passauer Straße 5-7 mbH, Co-Managing Director at Objektgesellschaft München Jahnstraße 41 und Klenzestraße, Managing Director at Santo Venture Capital GmbH, Chief Executive Officer & General Partner at ATHOS KG and Managing Director at ATS Beteiligungsverwaltung GmbH. He is also Co-Managing Director at AT Impf GmbH and Managing Director at Apceth Biopharma Manufacturing Co. Gmbh and on the board of 6 other companies.
In the past Helmut Jeggle occupied the position of Managing Director at Klinge Pharma GmbH (Bayern), Chairman-Management Board at Sidroga AG, Managing Director at apceth Biopharma GmbH, Head-Business Planning & Analysis at H e x a l AG and Head-Business Planning & Analysis at Sandoz International GmbH.
Helmut Jeggle received an undergraduate degree from Neu-Ulm University of Applied Sciences and an MBA from Stuttgart Institute of Management & Technology GmbH.